πŸ‡ΊπŸ‡Έ FDA
Patent

US 8748472

Stabilized formulations of CNS compounds

granted A61KA61K31/5377A61K9/0004

Quick answer

US patent 8748472 (Stabilized formulations of CNS compounds) held by Supernus Pharmaceuticals, Inc. expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K31/5377, A61K9/0004, A61K9/16, A61K9/1623